RecruitingNot Applicable

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

United States150 participantsStarted 2023-11-01

Plain-language summary

The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults that is able to consent (≥ 18 years of age) * Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals * not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\] Exclusion Criteria: * unable to consent and \< 18 years of age * currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)

What they're measuring

Number of participants at each endotoxin activity level after surgery.

Timeframe: Day 1 (within 30 minutes postoperative)

Corelation of endotoxin activity level with post-operative infectious complication

Timeframe: up to 24 hours

Trial details

NCT IDNCT04669886

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-30

Contact for this trial

Hemendra N Shah

3052433246 hns35@miami.edu

View on ClinicalTrials.gov More Nephrolithiasis trials